Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ANHVV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TZ-dSA3-4
|
|||||
| Synonyms |
TZ-dSA3-4
Click to Show/Hide
|
|||||
| Organization |
Qingdao University.; Capital Medical University.; Academy of Military Medical Sciences.; Chinese Academy of Medical Sciences & Peking Union Medical College.
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
diABZI STING agonist 3
|
Payload Info | ||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines
|
|||||